---
title: "映恩生物擬發行人民幣股份上交所科創板上市"
description: "映恩生物－B 公佈，建議發行人民幣股份及於上海證券交易所科創板上市。目前，董事會並無有關建議發行的任何其他計劃，亦無就建議發行人民幣股份向相關監管機構作出任何申請。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261765807.md"
published_at: "2025-10-19T09:56:17.000Z"
---

# 映恩生物擬發行人民幣股份上交所科創板上市

> 映恩生物－B 公佈，建議發行人民幣股份及於上海證券交易所科創板上市。目前，董事會並無有關建議發行的任何其他計劃，亦無就建議發行人民幣股份向相關監管機構作出任何申請。

映恩生物－B(09606.HK) 公佈，建議發行人民幣股份及於上海證券交易所科創板上市。目前，董事會並無有關建議發行的任何其他計劃，亦無就建議發行人民幣股份向相關監管機構作出任何申請。

### Related Stocks

- [09606.HK - 映恩生物-B](https://longbridge.com/zh-HK/quote/09606.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| APT Electronics to Convert Over 21.7 Million Domestic Shares to Hong Kong-Listed Shares | APT Electronics to Convert Over 21.7 Million Domestic Shares to Hong Kong-Listed Shares | [Link](https://longbridge.com/zh-HK/news/275450557.md) |
| Retal Urban Development Signs SSA With Alfozan Holding For Ajdan Co Shares | Retal Urban Development Company SJSC :RETAL URBAN DEVELOPMENT - SIGNS SHARE SWAP AGREEMENT WITH ALFOZAN HOLDING FOR AJDA | [Link](https://longbridge.com/zh-HK/news/275995528.md) |
| TYK Medicines Gets Regulatory Nod to List 4.6 Million Converted Shares on Hong Kong Bourse | TYK Medicines Gets Regulatory Nod to List 4.6 Million Converted Shares on Hong Kong Bourse | [Link](https://longbridge.com/zh-HK/news/275738444.md) |
| Contel Technology Announces Charge Of Shares Of The Controlling Shareholder | Contel Technology Co Ltd :CEO LAM KEUNG CHARGES SHARES OF P.GRAND IN FAVOUR OF CHARGEE AS SECURITY FOR A LOAN FACILITYP. | [Link](https://longbridge.com/zh-HK/news/275835556.md) |
| Nomura Adjusts Innovent Biologics' Price Target to HK$114.64 From HK$105.08, Keeps at Buy | Nomura Adjusts Innovent Biologics' Price Target to HK$114.64 From HK$105.08, Keeps at Buy | [Link](https://longbridge.com/zh-HK/news/275882948.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。